Dr. Linseman – Neuroscience Grant Writer and Editor: PhD in Pharmacology
Neuroscience Grant Writer and Editor Dr. Linseman is an experienced neuroscientist with expertise in neurodegeneration, neurotrauma, and neuropharmacology. He received his B.S. in Biology and Chemistry from the University of Michigan in 1987 and a Ph.D. in Pharmacology from the University of Michigan in 2000. From 1987-1995, he was a research assistant at the Upjohn Pharmaceutical Company in Kalamazoo, Michigan where he worked in the fields of toxicology and cardiovascular disease. Beginning in 2000, he did 5 years of postdoctoral training at the Denver Veterans Affairs Medical Center studying mechanisms of neuronal apoptosis. For the past 14 years, he has ran his own research program focused on elucidating molecular mechanisms of neuronal cell death in degenerative disorders and episodes of neurotrauma, with a particular emphasis on amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), Alzheimer’s disease (AD), and traumatic brain injury (TBI). He has submitted more than 50 independent investigator grant applications and received funding from the NIH (R01) and the VA (Merit Review) and he has published more than 70 peer-reviewed papers. According to the Web of Science, his published works have nearly 3000 citations and he has an author H-index of 30. Dr. Linseman has served as a peer reviewer for nearly 30 journals including a dozen neuroscience journals. He has also served on peer review study sections for the NIH (R01, R21, R15, and Fellowship panels), the VA (Merit Review panels), and the Department of Defense, as well as multiple foundation granting agencies. In addition to his significant research and peer review responsibilities, Dr. Linseman mentors undergraduate and graduate students and postdocs in the laboratory and teaches university courses in neuropharmacology, advanced cell signaling, and ethical dilemmas in neurology.
To work with Neuroscience Grant Writer and Editor Dr. Linseman, please visit our quote page and request him in the description area.
Key words: Alzheimer’s disease, Amyotrophic lateral sclerosis, Apoptosis, Mitochondrial dysfunction, Mouse models, Neurodegeneration, Neuroprotection, Neurotrauma, Nitrosative stress, Nutraceuticals, Oxidative stress, Parkinson’s disease, Traumatic brain injury, neuroscience grant writer